ADJUVANT THERAPY OF COLORECTAL-CANCER - AN OVERVIEW

被引：5

作者：

WIRTH, A ^{[1
]}

GREEN, M ^{[1
]}

ZALCBERG, JR ^{[1
]}

机构：

[1] REPATRIAT GEN HOSP,DEPT MED ONCOL,PRIVATE BAG 1,HEIDELBERG,VIC 3081,AUSTRALIA

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1991年 / 61卷 / 01期

关键词：

ADJUVANT THERAPY; COLORECTAL CANCER; LEUCOVORIN; LEVAMISOLE; 5-FLUOROURACIL;

D O I：

10.1111/j.1445-2197.1991.tb00119.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The substantial recurrence rate of colorectal cancer following potentially curative resection has fuelled the search for effective adjuvant therapy. Previous trials using 5-fluorouracil (5-FU) as a single agent or in combination chemotherapy regimens have not demonstrated meaningful benefits, an impression reflected in the results of a meta-analysis encompassing large patient numbers. Newer developments utilizing intraportal chemotherapy and the combination of 5-FU and levamisole have resulted in lower recurrence rates and improved survival in patients with colon cancer. In advanced disease, the biochemical modulation of 5-FU by Leucovorin has been shown to prolong survival in some studies. Combined chemotherapy and radiotherapy or chemotherapy alone have shown promising results in rectal cancer. These developments have now been incorporated into ongoing trials.

引用

页码：13 / 22

页数：10

共 59 条

[1]

Giles G.G., Armstrong B.K., Smith L.R., Cancer in Australia 1982, (1987)

[2]

Cohen A.M., Shanks B., Friedman M.A., Colorectal Cancer, Cancer: Principles and Practice of Oncology, (1989)

[3]

Chapuis P.H., Dent O.F., Fisher R., Et al., A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer, Brit. J. Surg., 72, pp. 698-702, (1985)

[4]

Dukes C.E., The classification of cancer of the rectum, The Journal of Pathology and Bacteriology, 35, pp. 323-332, (1932)

[5]

Wolmark N., Fisher B., Wieand H.S., The prognostic value of the modifications of the Dukes' C class of colorectal cancer, Ann. Surg., 203, pp. 115-122, (1986)

[6]

Manual for Sraging of Cancer, (1988)

[7]

Adjuvant therapy of colon cancer: Results of a prospectively randomized trial, N. Engl. J. Med., 310, pp. 737-743, (1984)

[8]

Taylor I., Adjuvant cytotoxic chemotherapy for colorectal cancer: the present position, ANZ Journal of Surgery, 58, pp. 687-691, (1988)

[9]

Holden W.D., Dixon W.J., A study of the use of triethylene‐thiophosphoramide as an adjuvant to surgery in the treatment of colorectal cancer, Cancer Chemorher. Rep., 16, pp. 129-134, (1962)

[10]

Higgins G.A., Serlin O., Dwight R.W., The Veterans' Surgical Adjuvant Group: Interim report, Cancer Chemorher. Rep., 16, pp. 141-148, (1962)

← 1 2 3 4 5 6 →